An inhibitor of steroid 5α-reductase
Technical Support & Resources

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

Dutasteride

Item No. 15956

Technical Information
Formal Name
N-[2,5-bis(trifluoromethyl)phenyl]-2,4aR,4bS,5,6,6aS,7S,8,9,9aS,9bS,10,11,11aR-tetradecahydro-4a,6a-dimethyl-2-oxo-1H-indeno[5,4-f]quinoline-7-carboxamide
CAS Number
164656-23-9
Molecular Formula
C27H30F6N2O2
Formula Weight
Purity
≥98%
Formulation
A crystalline solid
DMF: 30 mg/mlDMF:PBS(pH7.2) (1:2): 0.3 mg/mlDMSO: 10 mg/mlEthanol: 10 mg/ml
λmax
206, 241, 278 nm
SMILES
O=C1C=C[C@@]2(C)[C@](CC[C@]3([H])[C@]2([H])CC[C@@]4(C)[C@@]3([H])CC[C@@H]4C(NC5=CC(C(F)(F)F)=CC=C5C(F)(F)F)=O)([H])N1
InChi Code
InChI=1S/C27H30F6N2O2/c1-24-11-9-17-15(4-8-21-25(17,2)12-10-22(36)35-21)16(24)6-7-19(24)23(37)34-20-13-14(26(28,29)30)3-5-18(20)27(31,32)33/h3,5,10,12-13,15-17,19,21H,4,6-9,11H2,1-2H3,(H,34,37)(H,35,36)/t15-,16-,17-,19+,21+,24-,25+/m0/s1
InChi Key
JWJOTENAMICLJG-QWBYCMEYSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Add

    Add

    Cayman Chemical
    Visit Our Cancer Resource Center
    Find Tools & Resources to Study the Hallmarks of Cancer
    • Cancer cell signaling & regulation
    • Cancer metabolism
    • Tumor microenvironment
    EXPLORE NOW
    Product Description

    Dutasteride is a dual inhibitor of 5α-reductase types I and II (Kis = 6 and 7 nM, respectively).1,2,3 Its inhibition is time-dependent inhibitor with apparent Ki values of 17 and 4.3 nM at 10- and 30-minute reaction times, respectively.1 Dutasteride decreases prostate weight in a rat model of benign prostatic hypertrophy induced by testosterone after castration when administered daily for 28 days at doses of 0.045 mg/kg as a solution or 0.756 mg/kg in subcutaneous microspheres.4 It also decreases prostate weight in large probasin-large T antigen mice, a transgenic model of prostate cancer.5 Formulations containing dutasteride have been used in the treatment of benign prostatic hyperplasia.

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Makridakis, N., and Reichardt, J.K. Pharmacogenetic analysis of human steroid 5α reductase type II: Comparison of finasteride and dutasteride. J. Mol. Endocrinol. 34(3), 617-623 (2005).

    2. Bramson, H.N., Hermann, D., Batchelor, K.W., et alUnique preclinical characteristics of GG745, a potent dual inhibitor of 5AR. J. Pharmacol. Exp. Ther. 282(3), 1496-1502 (1997).

    3. Tian, G., Stuart, J.D., Moss, M.L., et al17β-(N-tert-butylcarbamoyl)-4-aza-5 α-androstan-1-en-3-one is an active site-directed slow time-dependent inhibitor of human steroid 5 α-reductase 1. Biochemistry 33(8), 2291-2296 (1994).

    4. Xie, X., Yang, Y., Chi, Q., et alControlled release of dutasteride from biodegradable microspheres: In vitro and in vivo studies. PLoS One 9(12), e114835 (2014).

    5. Shao, T.C., Li, H., Ittmann, M., et alEffects of dutasteride on prostate growth in the large probasin-large T antigen mouse model of prostate cancer. J. Urol. 178(4 Pt. 1), 1521-1527 (2007).